Literature DB >> 31100051

Opioid discontinuation as an institutional mandate: Questions and answers on why we wrote to the Centers for Disease Control and Prevention.

Stefan G Kertesz1, Sally L Satel2, James DeMicco3, Richard C Dart4, Daniel P Alford5.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31100051     DOI： 10.1080/08897077.2019.1613830

Source DB:  PubMed          Journal:  Subst Abus        ISSN： 0889-7077            Impact factor:   3.716


× No keyword cloud information.
  3 in total

1.  Capsule Commentary on Sullivan et al., Primary Care Opioid Taper Plans Are Associated with Sustained Opioid Dose Reduction.

Authors:  Jessica A Chen
Journal:  J Gen Intern Med       Date:  2019-11-11       Impact factor: 5.128

2.  "I felt like I had a scarlet letter": Recurring experiences of structural stigma surrounding opioid tapers among patients with chronic, non-cancer pain.

Authors:  Allyn Benintendi; Sarah Kosakowski; Pooja Lagisetty; Marc Larochelle; Amy S B Bohnert; Angela R Bazzi
Journal:  Drug Alcohol Depend       Date:  2021-03-18       Impact factor: 4.492

3.  Damaging State Legislation Regarding Opioids: The Need To Scrutinize Sources Of Inaccurate Information Provided To Lawmakers.

Authors:  Michael E Schatman; Hannah Shapiro
Journal:  J Pain Res       Date:  2019-11-11       Impact factor: 3.133
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.